Study women with atopic dermatitis during pregnancy
Treatments studied
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This is an observational study that looks back at medical and pharmacy records of women with atopic dermatitis around pregnancy. It may help researchers better understand how this condition affects pregnant patients and pregnancy-related care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have continuous health and pharmacy insurance coverage for at least 6 months before and through your estimated last menstrual period (LMP).
- You were diagnosed with atopic dermatitis (AD, a type of eczema) within the 1 year before your estimated LMP through the pregnancy period.
- You can have records from clinic/claims showing the AD diagnosis around that timeframe.
- You will be included only if you also meet any additional trial rules for this study (there may be exclusions not listed here).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 study looks at how dupilumab works in people with moderate-to-severe atopic dermatitis (eczema), and whether the mechanism differs across ethnic backgrounds. If you’re eligible, it may help doctors understand who benefits most from dupilumab.
This study looks at how well Dupilumab works over time for people with atopic dermatitis (eczema). It includes adults, teens, and children ages 6 and up.
This trial studies why eczema (“atopic dermatitis”) varies in severity even when people receive the medicine dupilumab. It may help doctors better predict who responds well and how to monitor treatment.
This trial studies how the body’s “molecular signals” change in the skin after using dupilumab for eczema. It may help researchers understand who benefits most from treatment.
This study looks at how well dupilumab works for children and teens with severe eczema (atopic dermatitis) even when the rash is not widespread. It aims to see if the treatment helps with itching, quality of life, and rashes in visible or sensitive areas.
This study looks at women who used a topical eczema cream called ruxolitinib (Opzelura) or steroid creams during pregnancy. The goal is to compare pregnancy outcomes and baby health up to one year after birth.
Hear when a new Adverse Pregnancy Outcomes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.